Skip to Main Content
Contribute Try STAT+ Today

In its latest bid to boost clinical trial transparency, the U.K. government will automatically register new studies with an independent registry, a move that is designed to lessen reliance on companies, universities, and researchers for up-to-date submissions.

The effort will begin in January 2022 as a partnership between the Health Research Authority and ISRCTN, a registry in London that is part of a World Health Organization network of globally recognized trial registries. Trial registrations will be based on ethics committee approvals for all new studies from around the country, which are centrally housed with the HRA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment